Search Results - "Vorst, Maurice J."

Patients' preferences for participation in treatment decision-making at the end of life: qualitative interviews with advanced cancer patients by Brom, Linda, Pasman, H Roeline W, Widdershoven, Guy A M, van der Vorst, Maurice J D L, Reijneveld, Jaap C, Postma, Tjeerd J, Onwuteaka-Philipsen, Bregje D

“…Patients are often encouraged to participate in treatment decision-making. Most studies on this subject focus on choosing between different curative treatment…”
Get full text

Experiences and perspectives of patients with advanced cancer regarding work resumption and work retention: a qualitative interview study by Beerda, Donna C. E., Zegers, Amber D., van Andel, Emma S., Becker-Commissaris, Annemarie, van der Vorst, Maurice J. D. L., Tange, Dorien, Duijts, Saskia F. A., Brom, Linda

“…Purpose Being able to work improves the quality of life of patients with cancer. Much is known about the return to work process of cancer survivors. Yet,…”
Get full text

A randomized controlled trial on the efficacy of life review therapy targeting incurably ill cancer patients: do their informal caregivers benefit? by Kleijn, Gitta, Lissenberg-Witte, Birgit I., Bohlmeijer, Ernst T., Willemsen, Vincent, Becker-Commissaris, Annemarie, Eeltink, Corien M., Bruynzeel, Anna M.E., van der Vorst, Maurice J., Cuijpers, Pim, Verdonck-de Leeuw, Irma M.

“…Purpose Investigate whether Life Review Therapy and Memory Specificity Training (LRT-MST) targeting incurably ill cancer patients may also have a beneficial…”
Get full text

Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin by van der Vorst, Maurice J D L, Neefjes, Elisabeth C W, Toffoli, Elisa C, Oosterling-Jansen, Jolanda E W, Vergeer, Marije R, Leemans, C René, Kooistra, Menno P, Voortman, Jens, Verheul, Henk M W

“…Three-weekly high-dose cisplatin (100 mg/m ) is considered the standard systemic regimen given concurrently with postoperative or definitive radiotherapy in…”
Get full text

Aberrant immunophenotype of blasts in myelodysplastic syndromes is a clinically relevant biomarker in predicting response to growth factor treatment by Westers, Theresia M., Alhan, Canan, Chamuleau, Martine E.D., van der Vorst, Maurice J.D.L., Eeltink, Corien, Ossenkoppele, Gert J., van de Loosdrecht, Arjan A.

“…Myelodysplastic syndromes (MDS) are a group of clonal disorders of the bone marrow characterized by peripheral cytopenias. Standard treatment in low- and…”
Get full text

The association between palliative care team consultation and hospital costs for patients with advanced cancer: An observational study in 12 Dutch hospitals by Brinkman‐Stoppelenburg, Arianne, Polinder, Suzanne, Olij, Branko F., den Berg, Barbara, Gunnink, Nicolette, Hendriks, Mathijs P., Linden, Yvette M., Nieboer, Daan, Padt‐Pruijsten, Annemieke, Peters, Liesbeth A., Roggeveen, Brenda, Terheggen, Frederiek, Verhage, Sylvia, Vorst, Maurice J., Willemen, Ingrid, Vergouwe, Yvonne, Heide, Agnes

“…Background Early palliative care team consultation has been shown to reduce costs of hospital care. The objective of this study was to investigate the…”
Get full text

Accuracy of the Delirium Observational Screening Scale (DOS) as a screening tool for delirium in patients with advanced cancer by Neefjes, Elisabeth C W, van der Vorst, Maurice J D L, Boddaert, Manon S A, Verdegaal, Bea A T T, Beeker, Aart, Teunissen, Saskia C C, Beekman, Aartjan T F, Zuurmond, Wouter W A, Berkhof, Johannes, Verheul, Henk M W

“…The Delirium Observation Screening Scale (DOS) was developed to facilitate early recognition of delirium by nurses during routine clinical care. It has shown…”
Get full text

Radiofrequency Ablation to Improve Survival After Conversion Chemotherapy for Colorectal Liver Metastases by Nielsen, Karin, Scheffer, Hester J., Volders, José H., van der Vorst, Maurice J. D. L., van Tilborg, Aukje A. J. M., Comans, Emile FI, de Lange-de Klerk, E. S. M., Sietses, Colin, Meijer, Sybren, Meijerink, Martijn R., van den Tol, M. Petrousjka

“…Introduction Systemic chemotherapy is able to convert colorectal liver metastases (CRLM) that are initially unsuitable for local treatment into locally…”
Get full text

Quality of integrated female oncofertility care is suboptimal: A patient‐reported measurement by Berg, Michelle, Kaal, Suzanne E. J., Schuurman, Teska N., Braat, Didi D. M., Mandigers, Caroline M. P. W., Tol, Jolien, Tromp, Jacqueline M., Vorst, Maurice J. D. L., Beerendonk, Catharina C. M., Hermens, Rosella P. M. G.

“…Background Clinical practice guidelines recommend to inform female cancer patients about their infertility risks due to cancer treatment. Unfortunately, it…”
Get full text

Prophylactic treatment for delayed chemotherapy-induced nausea and vomiting after non-AC based moderately emetogenic chemotherapy: a systematic review of randomized controlled trials by van der Vorst, Maurice J. D. L, Neefjes, Elisabeth C. W., Konings, Inge R. H. M., Verheul, Henk M. W.

“…Purpose Delayed chemotherapy-induced nausea and vomiting (CINV) remains an important adverse effect of moderately emetogenic chemotherapy not containing…”
Get full text

Optimal treatment of opioid induced constipation in daily clinical practice - an observational study by Neefjes, Elisabeth C W, van der Wijngaart, Hanneke, van der Vorst, Maurice J D L, Ten Oever, Diederik, van der Vliet, Hans J, Beeker, Aart, Rhodius, Christiaan A, van den Berg, Hendrik P, Berkhof, Johannes, Verheul, Henk M W

“…Opioids are prescribed in over 40% of patients with advanced cancer, but side effects occur frequently. In this study we evaluated the development and…”
Get full text

Identification of patients with cancer with a high risk to develop delirium by Neefjes, Elisabeth C. W., Vorst, Maurice J. D. L., Verdegaal, Bertha A. T. T., Beekman, Aartjan T. F., Berkhof, Johannes, Verheul, Henk M. W.

“…Delirium deteriorates the quality of life in patients with cancer, but is frequently underdiagnosed and not adequately treated. In this study, we evaluated the…”
Get full text

Outcomes and Feasibility of an Occupational Care Programme (TERRA) to Support Work Ability of Rare and Advanced Cancer Patients: A Report of 7 Cases by Hosman, Floortje L, Rozemeijer, Sascha C A, Zegers, Amber D, Becker-Commissaris, Annemarie, Klümpen, Heinz-Josef, van der Vorst, Maurice J D L, Brom, Linda, Duijts, Saskia F A

“…Advancements in the field of oncology are allowing patients to live longer, with enhanced quality of life (QoL). Accordingly, more patients with cancer are…”
Get more information

Olanzapine Versus Haloperidol for Treatment of Delirium in Patients with Advanced Cancer: A Phase III Randomized Clinical Trial by der Vorst, Maurice J.D.L., Neefjes, Elisabeth C.W., Boddaert, Manon S.A., Verdegaal, Bea A.T.T., Beeker, Aart, Teunissen, Saskia C.C., Beekman, Aartjan T.F., Wilschut, Janneke A., Berkhof, Johannes, Zuurmond, Wouter W.A., Verheul, Henk M.W.

“…Background Treatment of delirium often includes haloperidol. Second‐generation antipsychotics like olanzapine have emerged as an alternative with possibly…”
Get full text

Aiming for a Better Understanding and Management of Cancer‐Related Fatigue by Neefjes, Elisabeth C.W., Vorst, Maurice J.D.L., Blauwhoff‐Buskermolen, Susanne, Verheul, Henk M.W.

“…Cancer‐related fatigue (CRF) is a serious symptom of patients with cancer and deteriorates their daily quality of life. Whereas fatigue is a common problem in…”
Get full text

Muscle mass as a target to reduce fatigue in patients with advanced cancer by Neefjes, Elisabeth C.W., Hurk, Renske M., Blauwhoff‐Buskermolen, Susanne, Vorst, Maurice J.D.L., Becker‐Commissaris, Annemarie, Schueren, Marian A.E., Buffart, Laurien M., Verheul, Henk M.W.

“…Background Cancer‐related fatigue (CRF) reduces quality of life and the activity level of patients with cancer. Cancer related fatigue can be reduced by…”
Get full text

The Impact of Palliative Care Team Consultation on Quality of Life of Patients with Advanced Cancer in Dutch Hospitals: An Observational Study by Brinkman-Stoppelenburg, Arianne, Vergouwe, Yvonne, Booms, Monique, Hendriks, Mathijs P, Peters, Liesbeth A, Quarles van Ufford-Mannesse, Patricia, Terheggen, Frederiek, Verhage, Sylvia, van der Vorst, Maurice J D L, Willemen, Ingrid, Polinder, Suzanne, van der Heide, Agnes

“…Experimental studies have shown that palliative care team (PCT) involvement can improve quality of life (QoL) and symptom burden of patients with advanced…”
Get more information

Unusual presentation of granulosa cell tumor of the ovary by van der Vorst, Maurice J D L, Bleeker, Maaike C G, Boven, Epie

Get full text

Metoclopramide, Dexamethasone, or Palonosetron for Prevention of Delayed Chemotherapy‐Induced Nausea and Vomiting After Moderately Emetogenic Chemotherapy (MEDEA): A Randomized, Phase III, Noninferiority Trial by Vorst, Maurice J.D.L., Toffoli, Elisa C., Beusink, Marlien, Linde, Myra E., Voorthuizen, Theo, Brouwer, Saskia, Zweeden, Annette A., Vrijaldenhoven, Suzan, Berends, Johan C., Berkhof, Johannes, Verheul, Henk M.W.

“…Background For the prevention of chemotherapy‐induced nausea and vomiting (CINV) during the delayed phase (24–120 hours) after moderately emetogenic…”
Get full text

Olanzapine Versus Haloperidol for Treatment of Delirium in Patients with Advanced Cancer: A Phase III Randomized Clinical Trial by van der Vorst, Maurice J D L, Neefjes, Elisabeth C W, Boddaert, Manon S A, Verdegaal, Bea A T T, Beeker, Aart, Teunissen, Saskia C C, Beekman, Aartjan T F, Wilschut, Janneke A, Berkhof, Johannes, Zuurmond, Wouter W A, Verheul, Henk M W

“…Treatment of delirium often includes haloperidol. Second-generation antipsychotics like olanzapine have emerged as an alternative with possibly fewer side…”
Get full text